Top Biotech Companies in Salt Lake City, UT (34)
As a global healthcare company, we understand customer needs and innovate and deliver medical solutions that transform patient care. Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide...
Merit Medical Systems, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show rising revenue through 2025 with further growth in early 2026, and guidance points to continued expansion for the full year. Feedback suggests demand is broad-based across the U.S. and faster-growing international regions.
Profitability: Gross margin improved year over year and non‑GAAP operating margin edged higher in the latest quarter, indicating operating leverage alongside growth. Free cash flow also increased, and management targets further margin improvement.
Strong Market Position & Advantage: The company reports leadership in core disposable niches such as inflation devices, control syringes, hemostasis/waste systems, tubing/manifolds, as well as SCOUT breast localization and embolotherapy microspheres. Independent industry sources list the firm among top players in hemostasis valves and embolization particles.
ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests.
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com. Together with...
Stryker's Top Stability & Growth Strengths
Strong Revenue Growth: Recent results show double-digit annual sales expansion through 2025, with management guiding to continued organic growth into 2026.
Strong Market Position & Advantage: Evidence highlights leadership in orthopedic robotics and top-tier standings among global medtech peers, with notable share in joint replacement and integrated OR technologies.
Diversified Revenue Streams: Multiple segments and recent vascular-focused acquisitions broaden growth drivers and reduce reliance on any single category.
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial...
Varian's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry analyses frequently describe external‑beam radiotherapy as a Varian–Elekta near‑duopoly, with Varian often cited at or near the top. Feedback suggests a large installed base, leading software stack, and a broad global service footprint reinforce this position.
Strong Revenue Growth: Company and trade updates state the Varian segment has posted year‑over‑year revenue growth across multiple recent periods within Siemens Healthineers, alongside positive order momentum and a growing backlog. Feedback suggests recent quarterly trends point to continued demand for systems, software, and services.
Strategic Partnerships: Integration with Siemens Healthineers provides access to imaging, diagnostics, and digital platforms, enabling end‑to‑end oncology workflows and cross‑selling advantages. Feedback suggests this parent‑level backing strengthens global reach and execution in tenders.
We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives,...
Myriad Genetics is a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases.
.png)
Ancestry is the global leader in family history and consumer genomics. Every day, around the world, we help curious people like you embark on journeys of personal discovery to enrich lives. With our unparalleled collection of more than 40 billion records from more than 80 countries and 23+ million people in our growing DNA network, Ancestry helps customers discover their family...
Ancestry's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company communications and industry coverage consistently depict Ancestry as the category leader, citing tens of billions of records, millions of subscribers, and the world’s largest consumer DNA network. Blackstone’s 2020 acquisition and a weakened rival landscape (e.g., 23andMe’s 2025 bankruptcy) reinforce its durable leadership.
Product Line Growth: Content and features expanded with 243 new historical collections in 2025, the largest-ever ethnicity update, and the iMemories acquisition adding media digitization. AI-enabled processing accelerates turning archives into searchable data, signaling ongoing product and data-scale growth.
Market Expansion: The company launched services in Italy and the Netherlands in 2025 and reported strong subscriber scale alongside rising community uploads. A multiyear partnership with the U.S. National Archives supports continued content expansion that benefits multiple markets.
CenExel Centers of Excellence is proud to support a variety of clinical research as a network which includes; CenExel ACT, ACMR, AMRI, CBH, CIT, CNR, CNS, FCR, HRI, iResearch, JBR and RCA. Visit the bio link to learn more about the indications we support and how CenExel can help your clinical trial be successful.
Blackrock Neurotech builds implantable brain technology that changes lives. Our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders.
SINTX is a spinal and orthopedic implant company using its silicon nitride ceramic tech to develop spine and total joint implants.
Applied Biosensors offers to commercialize decades of research on polymer-based, low-cost multi-analyte biosensors.
Known Medicine primarily engages in ensuring to provide the right treatment for every patient by combining biology research & AI techniques.
Lipocine is a specialty pharmaceutical company that develops and commercializes pharmaceutical products.
ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing IV therapy systems, software, solutions, and consumables.
Dynatronics is a medical device company committed to providing high-quality restorative products designed to accelerate one to their optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine...
Sorenson Forensics is a biotechnology company that offers DNA casework and validation services.
Biomerics LLC is a leading vertically integrated medical device contract manufacturer specializing in the interventional device market. The company provides a comprehensive range of engineered components and finished devices, focusing on innovative polymer solutions for diagnostic and interventional procedures. They serve as a trusted partner to many of the world's top medical device OEMs across cardiovascular, structural heart, and vascular...
Progenitor is a Reprogramming System Technology for the generation of highly pluripoptent induced pluripotent stem cells.
Pioneering Diagnostics A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine...
bioMérieux's Top Stability & Growth Strengths
Strong Market Position & Advantage: BioMérieux is positioned as a leader in niche in vitro diagnostics areas, particularly clinical microbiology and syndromic molecular testing, supported by a broad global footprint and strong positions for key platforms. Segment leadership is reinforced by ongoing installed-base expansion for flagship systems.
Strong Revenue Growth: Sales show sustained organic growth across 2024 and 2025, with guidance indicating continued mid-single-digit expansion in 2026. Growth is attributed to momentum in molecular biology, microbiology, and industrial applications, with newer platforms scaling rapidly.
Healthy Cash Flow: Free cash flow is described as strengthening materially alongside rising profitability metrics, indicating solid cash conversion as the business grows. This cash generation supports continued investment capacity while maintaining operating performance improvements.
